or
Bookmark and Share
5-substituted pyrazolo[4,3-D]pyrimidin-7-ones
   
Document Number
US Patent 6235742
Issued Date
May 22, 2001
Link
Map
Abstract
Compounds are disclosed which are useful as PDE1 inhibitors. The compounds have the formula: ##STR1##
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
22
Comments:
no comments yet
Owner
Pfizer Inc. (New York, NY)
Published
May 22, 2001
Application Number
09/176,166
Filed
October 21, 1998
US Classification
514/249   514/228.5 514/234.5 514/250 514/252.02 514/252.16 514/262.1 544/262
Int'l Classification
C07D   487/00   (20060101)   C07D   487/04   (20060101)  
Assistant Examiner
Priority Data
Oct 24, 1997 [GB] 9722520
USPTO Field of Search
544/262   514/258  
Related Patents
6734186 - Compounds for the treatment of female sexual dysfunction - Owned by Pfizer Inc. (New York, NY)

A method of treating a female suffering from FSD, in particular FSAD, is described. The method comprises delivering to the female an agent that is capable of potentiating cAMP in the sexual genitalia; wherein the agent is in an amount to cause potentiation of cAMP in the sexual genitalia of the female. The agent may be admixed with a pharmaceutically acceptable carrier, diluent or excipient.

6479493 - Methods for treatment of type I diabetes - Owned by Cell Pathways, Inc. (Horsham, PA)

Substituted condensation products of -benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of type I diabetes.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us